| Name | Ly-2624803 |
|---|---|
| Synonyms |
Ly-2624803
1-Piperazinepropanoic acid, 4-dibenz[b,f][1,4]oxazepin-11-yl-α,α-dimethyl- 3-[4-(Dibenzo[b,f][1,4]oxazepin-11-yl)-1-piperazinyl]-2,2-dimethylpropanoic acid |
| Description | LY2624803 is a novel potent histamine H1 and 5HT-2A receptor modulator in the pipeline for treating insomnia. Sleep Disorder Phase 2 Discontinued |
|---|---|
| References | References 1. Zisapel N. Expert Opin Investig Drugs. 2015 Mar;24(3):401-11. View Related Products by Target Histamine Receptor Sleep Disorder |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 554.3±60.0 °C at 760 mmHg |
| Molecular Formula | C22H25N3O3 |
| Molecular Weight | 379.452 |
| Flash Point | 289.0±32.9 °C |
| Exact Mass | 379.189606 |
| LogP | 2.64 |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C |
| Index of Refraction | 1.630 |